Neomycin And Polymyxin B Sulfates And Gramicidin Solution/ Drops
NDC Package 24208-790-62

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Neomycin And Polymyxin B Sulfates And Gramicidin (neomycin sulfate, polymyxin b sulfate and gramicidin) solution/ dropses is neomycin and Polymyxin B Sulfates and Gramicidin Ophthalmic Solution, USP is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. This formulation utilizes a solution/ drops delivery system. Marketed by Bausch & Lomb Incorporated, this product is identified by NDC 24208-790 and is authorized under FDA application ANDA064047.

Identification & Billing

NDC Package Code
24208-790-62
Package Description
1 BOTTLE, DROPPER in 1 CARTON / 10 mL in 1 BOTTLE, DROPPER
Product Code
11-Digit Billing Format
24208079062
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 310594 - gramicidin 0.025 MG / neomycin sulfate 1.75 MG / polymyxin B sulfate 10,000 UNT per ML Ophthalmic Solution
  • RxCUI: 310594 - gramicidin 0.025 MG/ML / neomycin 1.75 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Solution
  • RxCUI: 310594 - gramicidin 0.025 MG / neomycin (as neomycin sulfate) 1.75 MG / polymyxin B (as polymyxin B sulfate) 10,000 UNT per ML Ophthalmic Solution

Clinical Specifications

Proprietary Name
Neomycin And Polymyxin B Sulfates And Gramicidin
Non-Proprietary Name
Neomycin Sulfate, Polymyxin B Sulfate And Gramicidin
Substance Name
Gramicidin; Neomycin Sulfate; Polymyxin B Sulfate
Dosage Form
Solution/ Drops - A solution which is usually administered in a drop-wise fashion.
Administration Route
Ophthalmic - Administration to the external eye.
Usage Information
Neomycin and Polymyxin B Sulfates and Gramicidin Ophthalmic Solution, USP is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. Such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis.

Regulatory & Marketing

Labeler Name
Bausch & Lomb Incorporated
Product Type
Human Prescription Drug
FDA Application #
ANDA064047
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-31-1996
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24208-790-62 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 10 ml in 1 bottle, dropper of Neomycin And Polymyxin B Sulfates And Gramicidin, a human prescription drug labeled by Bausch & Lomb Incorporated. This solution/ drops is formulated for ophthalmic use and contains gramicidin; neomycin sulfate; polymyxin b sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch & Lomb Incorporated on January 31, 1996. The current certification is valid through December 31, 2026.

How is this Bausch & Lomb Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24208079062. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24208-790-62
11-Digit CMS (5-4-2)
24208-0790-62

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.